William Bishai, M.D., Ph.D.
Dr. Bishai is a Professor and Co-Director for the Center for Tuberculosis Research, Department of Medicine, Division of Infectious Diseases, at Johns Hopkins School of Medicine in Baltimore, Maryland. He is also a Scientist at the Howard Hughes Medical Institute. His interests lie in the molecular pathogenesis of tuberculosis, cell division in mycobacteria, and the pathogenesis of caseation and cavitation. His research has yielded well over one hundred publications. He belongs to a number of professional societies, including the Infectious Diseases Society of America and the American Society for Microbiology.
Gerard J. Criner, M.D.
Dr. Criner is Chair and Professor of Thoracic Medicine and Surgery at Temple Lung Center in Philadelphia. He has served as a section chief for the past 23 years and served as president of medical staff, president of Temple University Physicians, and associate dean of clinical affairs. Dr. Criner was appointed to the Global Initiative for Obstructive Lung disease (GOLD) Board of Directors to serve from 2014 to 2018, and to the Medical Advisory Board of the COPD Foundation in 2014. His research interests include respiratory failure, lung volume reduction surgery, bronchoscopic lung reduction, and the prevention and treatment of acute COPD exacerbations.
Ann C. Halbower, M.D.
Dr. Halbower is a Professor of Pediatric Pulmonology at the Children’s Hospital and the University of Colorado Health Sciences Center in Aurora, Colorado. She received her medical degree from the University of Massachusetts Medical School. Her other specialties include pediatric sleep medicine and pulmonary disorders. In 2006, she received the Clinician Scientist Award from Johns Hopkins University. Dr. Halbower is also a Chair on the Health Policy Committee for the American Thoracic Society.
William Martone, MD, MS
Dr. Martone is a Professor of Medicine (Infectious Disease) at the University of Arizona College of Medicine. He received his medical degree at New York University School of Medicine. He served as Director of the Hospital Infections Program at the Centers for Disease Control and Prevention, Senior Vice President of Medimmune, and Executive Director at Cubist Pharmaceuticals. Prior to his Cubist position, he was Senior Executive Director of the National Foundation for Infectious Disease. Dr. Martone has over 100 scientific publications.
Graham Timmins, PhD
Dr. Timmins server as Avisa’s Chief Science Advisor and is Associate Professor of Medicinal Chemistry at the University of New Mexico. He has authored/co-authored over fifty publications and awarded numerous federal grants. He is co-inventor of the core Avisa platform technology. Dr. Timmins is also the founder of Spinceutica, a development stage pharmaceutical company.
Todd W. Rice, M.D., M.Sc.
Dr. Rice is an Associate Professor of Medicine and Associate Director of the Medical Intensive Care Unit at Vanderbilt University Hospital in Nashville, Tennessee. He received his medical degree from Indiana University. A prolific author, Dr. Rice has contributed to over two hundred publications. He is a leading expert in lung cancer, mediastinal diseases, and pneumonectomy. Dr. Rice possesses special expertise in lung diseases, lung transplantation and bronchoscopy.